TxCell gains Treg rights
French immunotherapy company TxCell has teamed up with Inserm Transfert, the tech transfer subsidiary of the French National Institute of Health and Medical Research Inserm, to develop immuno-suppressive regulatory T cells.
ADVERTISEMENT
Log in here to read the desired article.
ADVERTISEMENT
This author has not written his bio yet.
But we are proud to say that Maren Kühr contributed 246 entries already.
French immunotherapy company TxCell has teamed up with Inserm Transfert, the tech transfer subsidiary of the French National Institute of Health and Medical Research Inserm, to develop immuno-suppressive regulatory T cells.
For the second time, biotech communication start-up Labiotech hosted its event LBRefresh, this year in Paris, France. Participants enjoyed panel discussions, a start-up battle and intimate fireside chats…
Compassionate use is a treatment option that allows the use of an unauthorised medicine.
PromoKine’s new Cell Proliferation Assays are fast and sensitive and EdU-based.
The enhanced Taq DNA polymerase, available in standard and hot-start formats, offers a balance between performance and value.
Stop wasting time with data room software that doesn’t really improve your workflow.

